CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biostem Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biostem Technologies Inc
2836 Center Port Cir
Phone: (954) 380-8342p:954 380-8342 POMPANO BEACH, FL  33064-2136  United States Ticker: BSEMBSEM
Business Summary
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap2 is a placental-based allograft comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2021YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board Thomas J.Dugan 66 12/13/2023 12/13/2023
Chief Executive Officer, Director JasonMatuszewski 38 1/1/2019 1/1/2018
Chief Financial Officer Michael A.Fortunato 57 10/1/2022 10/1/2022
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Aladdin Trading & Co.
Beverly Hills LTD Inc.
BSEM
Caribbean Casino & Gaming Corp
CGAQD
Regenerative BioScience, Inc.

General Information
Number of Employees: 67 (As of 12/31/2010)
Outstanding Shares: 16,338,436 (As of 9/30/2024)
Shareholders: 432
Stock Exchange: OTC
Federal Tax Id: 870281305


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025